Skip to search formSkip to main contentSkip to account menu

Rescriptor

Known as: Pfizer Brand of Delavirdine Mesilate 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DelavirdineDelavirdine Mesylate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
169-173 News and Views WF IF.indd
suggested by the published data (see Fig. 1 on page 176). Several of Keiser and colleagues’ predictions provide fascinating… 
2000
2000
Delavirdine (Rescriptor).
  • Research initiative, treatment action : RITA
  • 2000
  • Corpus ID: 12277014
1999
1999
[The successes and problems in the treatment of HIV infection: a biochemist's view].
The problems of the effectiveness of the treatment of HIV-infected patients with 11 medicinal preparations and their combinations… 
1998
1998
An evaluation of drug cocktail combinations for their immunological value in preventing/remitting opportunistic infections.
  • M. Konlee
  • Positive health news
  • 1998
  • Corpus ID: 24386011
While it appears that protease inhibitors in combination therapies are saving lives, questions continue: (1) which combinations… 
1997
1997
Delavirdine (Rescriptor) approved.
The Food and Drug Administration (FDA) approved delavirdine (Rescriptor) for HIV-1 treatment in March. Delavirdine becomes the… 
1997
1997
Delavirdine (Rescriptor) approved.
1997
1997
Delavirdine gets FDA approval. Food and Drug Administration.
Delavirdine (Rescriptor), a non-nucleoside reverse transcriptase inhibitor, has received Food and Drug Administration (FDA… 
1997
1997
[New combination medications].
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are the latest drugs used to treat HIV infection. Three NNRTIs are… 
1997
1997
Delavirdine gets the green light.
The Food and Drug Administration (FDA) approved delavirdine (Rescriptor) under its accelerated approval guidelines. The non… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)